N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations

References

• Anand P, Kunnumakkara AB, Newman RA, et al. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–18.
   PubMed Web of Science ®Google Scholar
• Balimane PV, Chong S, Morrison RA. (2000). Current methodologies used for evaluation of intestinal permeability and absorption. J Pharmacol Toxicol Methods 44:301–12.
   PubMed Web of Science ®Google Scholar
• Beloqui A, Solinís MÁ, Rodríguez-Gascón A, et al. (2016). Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomed Nanotechnol 12:143–61.
   PubMed Web of Science ®Google Scholar
• Berginc K, Trontelj J, Basnet NS, et al. (2012). Physiological barriers to the oral delivery of curcumin. Pharmazie 67:518–24.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Guggi D, Pinter Y. (2004a). Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release 94:177–86.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Krauland AH, Leitner VM, et al. (2004b). Thiomers: potential excipients for non-invasive peptide delivery systems. Eur J Pharm Biopharm 58:253–63.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Weithaler A, Albrecht K, et al. (2006). Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Int J Pharm 317:76–81.
   PubMed Web of Science ®Google Scholar
• Bravo-Osuna I, Vauthier C, Farabollini A, et al. (2007). Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 28:2233–43.
   PubMed Web of Science ®Google Scholar
• Dezani TM, Dezani AB, Junior JB, et al. (2016). Single-pass intestinal perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: a study with antiretroviral drugs. Eur J Pharm Biopharm 104:131–9.
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. (2012). Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 64:557–70.
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, et al. (2008). Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70:633–40.
   PubMed Web of Science ®Google Scholar
• Gradauer K, Vonach C, Leitinger G, et al. (2012). Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties. Int J Nanomed 7:2523–34.
   PubMed Web of Science ®Google Scholar
• Gref R, Domb A, Quellec P, et al. (1995). The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 16:215–33.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang SP, Du YZ, et al. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 45:167–73.
   PubMed Web of Science ®Google Scholar
• Ireson CR, Jones DJ, Orr S, et al. (2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidem Biomar 11:105–11.
   PubMed Web of Science ®Google Scholar
• Jia L, Shen J, Zhang D, et al. (2012). In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol 50:523–9.
   PubMed Web of Science ®Google Scholar
• Kafedjiiski K, Krauland AH, Hoffer MH, et al. (2005). Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials 26:819–26.
   PubMed Web of Science ®Google Scholar
• Kast CE, Bernkop-Schnürch A. (2001). Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22:2345–52.
   PubMed Web of Science ®Google Scholar
• Khan J, Iiboshi Y, Cui L, et al. (1999). Role of intestinal mucus on the uptake of latex beads by Peyer's patches and on their transport to mesenteric lymph nodes in rats. JPEN J Parenter Enteral Nutr 23:19–23.
   PubMed Web of Science ®Google Scholar
• Lai SK, Wang YY, Hanes J. (2009). Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61:158–71.
   PubMed Web of Science ®Google Scholar
• Lai SK, Suk JS, Pace A, et al. (2011). Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials 32:6285–90.
   PubMed Web of Science ®Google Scholar
• Lancelot A, Sierra T, Serrano JL. (2014). Nanostructured liquid-crystalline particles for drug delivery. Expert Opin Drug Deliv 11:547–64.
   PubMed Web of Science ®Google Scholar
• Lian H, Zhang T, Sun J, et al. (2013). Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism. Mol Pharm 10:3447–58.
   PubMed Web of Science ®Google Scholar
• Liang X, Mao G, Ng KY. (2005). Effect of chain lengths of PEO–PPO–PEO on small unilamellar liposome morphology and stability: an AFM investigation. J Colloid Interf Sci 285:360–72.
   PubMed Web of Science ®Google Scholar
• Lim SJ, Kim CK. (2002). Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 243:135–46.
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Du Y, et al. (2014a). Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy. J Control Release 176:94–103.
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhang Y, Pan K, et al. (2014b). Self-emulsification of alkaline-dissolved clove bud oil by whey protein, gum arabic, lecithin, and their combinations. J Agric Food Chem 62:4417–24.
   PubMed Web of Science ®Google Scholar
• Luo Y, Teng Z, Li Y, et al. (2015). Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr Polym 122:221–9.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mehnert W, Lucks JS, et al. (1995). Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 41:62–9.
   Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002a). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Delivery Rev 54:S131–S55.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002b). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–8.
   PubMed Web of Science ®Google Scholar
• Makhlof A, Werle M, Tozuka Y, et al. (2010). Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin. Int J Pharm 397:92–5.
   PubMed Web of Science ®Google Scholar
• Marangoni AG, Narine SS. (2002). Physical properties of lipids. New York (NY): Marcel Dekker.
   Google Scholar
• Martien R, Loretz B, Thaler M, et al. (2007). Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? J Biomed Mater Res A 82:1–9.
   PubMed Web of Science ®Google Scholar
• Melissa G, Victor S, Silvia I, et al. (2015). Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity. Int J Nanomed 10:6541–53.
   PubMed Web of Science ®Google Scholar
• Meng F, Asghar S, Gao S, et al. (2015). A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease. Colloids Surf B Biointerfaces 134:88–97.
   PubMed Web of Science ®Google Scholar
• Mishra K, Dash AP, Swain BK, et al. (2009). Anti-malarial activities of andrographis paniculata and hedyotis corymbosa extracts and their combination with curcumin. Malar J 8:1–9.
   PubMed Web of Science ®Google Scholar
• Mohanty C, Sahoo SK. (2010). The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31:6597–611.
   PubMed Web of Science ®Google Scholar
• Moldéus P, Cotgreave IA. (1994). N-acetylcysteine. Meth Enzymol 234:482–92.
   PubMed Web of Science ®Google Scholar
• Naksuriya O, Okonogi S, Schiffelers RM, et al. (2014). Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials 35:3365–83.
   PubMed Web of Science ®Google Scholar
• Nandakumar DN, Nagaraj VA, Vathsala PG, et al. (2006). Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents Chemother 50:1859–60.
   PubMed Web of Science ®Google Scholar
• Nayak AP, Tiyaboonchai W, Patankar S, et al. (2010). Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces 81:263–73.
   PubMed Web of Science ®Google Scholar
• Papadopoulou V, Kosmidis K, Vlachou M, et al. (2006). On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm 309:44–50.
   PubMed Web of Science ®Google Scholar
• Pharmacopoeia Committee of P. R. China. (2015). Pharmacopoeia of the People’s Republic of China. Beijing: China Medical Science and Technology Press.
   Google Scholar
• Ravindranath V, Chandrasekhara N. (1980). Absorption and tissue distribution of curcumin in rats. Toxicology 16:259–65.
   PubMed Web of Science ®Google Scholar
• Roldo M, Hornof M, Caliceti P, et al. (2004). Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur J Pharm Biopharm 57:115–21.
   PubMed Web of Science ®Google Scholar
• Samuni Y, Goldstein S, Dean OM, et al. (2013). The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 1830:4117–29.
   PubMed Web of Science ®Google Scholar
• Selvamuthukumar S, Velmurugan R. (2012). Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy. Lipids Health Dis 11:159–66.
   PubMed Web of Science ®Google Scholar
• Shaikh J, Ankola DD, Beniwal V, et al. (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37:223–30.
   PubMed Web of Science ®Google Scholar
• Shen J, Wang Y, Ping Q, et al. (2009). Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release 137:217–23.
   PubMed Web of Science ®Google Scholar
• Sheng Y, Liu C, Yuan Y, et al. (2009). Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials 30:2340–48.
   PubMed Web of Science ®Google Scholar
• Soong R, Macdonald PM. (2007). PEG molecular weight and lateral diffusion of PEG-ylated lipids in magnetically aligned bicelles. Biochim Biophys Acta 1768:1805–14.
   PubMed Web of Science ®Google Scholar
• Su Z, Niu J, Xiao Y, et al. (2011). Effect of octreotide-polyethylene glycol (100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Mol Pharm 8:1641–51.
   PubMed Web of Science ®Google Scholar
• Su Z, Shi Y, Xiao Y, et al. (2013). Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization. Int J Pharm 447:281–92.
   PubMed Web of Science ®Google Scholar
• Su Z, Xing L, Chen Y, et al. (2014). Lactoferrin-modified poly (ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Mol Pharm 11:1823–34.
   PubMed Web of Science ®Google Scholar
• Suk JS, Lai SK, Wang YY, et al. (2009). The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials 30:2591–97.
   PubMed Web of Science ®Google Scholar
• Tønnesen HH. (2002). Solubility, chemical, and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Pharmazie 57:820–4.
   PubMed Web of Science ®Google Scholar
• Tan QY, Hu NN, Liu GD, et al. (2012). Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability. Arch Pharm Res 35:499–508.
   PubMed Web of Science ®Google Scholar
• Tang BC, Dawson M, Lai SK, et al. (2009). Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proc Natl Acad Sci U S A 106:19268–73.
   PubMed Web of Science ®Google Scholar
• Tobio M, Sanchez A, Vila A, et al. (2000). The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids Surf B Biointerfaces 18:315–23.
   PubMed Web of Science ®Google Scholar
• Wahlang B, Pawar YB, Bansal AK. (2011). Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 77:275–82.
   PubMed Web of Science ®Google Scholar
• Wahlström B, Blennow G. (1978). A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 43:86–92.
   PubMedGoogle Scholar
• Walkey CD, Olsen JB, Guo H, et al. (2012). Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134:2139–47.
   PubMed Web of Science ®Google Scholar
• Werle M, Hoffer M. (2006). Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111:41–6.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Chen X, Yang L, et al. (2013). Preparation and oral bioavailability study of curcuminoid-loaded microemulsion. J Agric Food Chem 61:3654–60.
   PubMed Web of Science ®Google Scholar
• Xu Q, Ensign LM, Boylan NJ, et al. (2015). Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo. ACS Nano 9:9217–27.
   PubMed Web of Science ®Google Scholar
• Yang L, Gao S, Asghar S, et al. (2015). Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells. Int J Biol Macromol 72:1391–401.
   PubMed Web of Science ®Google Scholar
• Yang M, Lai SK, Wang YY, et al. (2011). Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angew Chem Int Edit 50:2597–600.
   PubMed Web of Science ®Google Scholar
• Yang M, Lai SK, Yu T, et al. (2014). Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol. J Control Release 192:202–8.
   PubMed Web of Science ®Google Scholar
• Yu H, Huang Q. (2012). Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J Agric Food Chem 60:5373–9.
   PubMed Web of Science ®Google Scholar